©The Author(s) 2023.
World J Methodol. Sep 20, 2023; 13(4): 296-322
Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.296
Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.296
Table 1 Baseline features in 540 patients with post-COVID-19 cholangiopathy, n (%)
| Variable | Patients, n = 540 (100) |
| Sex | |
| Male | 69 (12.7) |
| Female | 26 (4.8) |
| Age > 50 year | 66 (12.2) |
| Liver enzymes | |
| High (> 45) | 507 (93.8) |
| Total bilirubin | |
| High (> 1.2 mg/dL) | 343 (63.5) |
| Alkaline phosphatase | |
| High (> 147 IU/L) | 488 (90.3) |
| Ultrasound findings | |
| Biliary ductal dilatation with fibrosis | 225 (41.6) |
| MRI Findings | |
| Bile duct thickening and enhancement | 258 (47.7) |
| Beading of intrahepatic ducts | 247 (45.7) |
| Peribiliary diffusion | 155 (28.7) |
| Histopathology with secondary sclerosing cholangitis | 402 (74.4) |
| Orthotopic liver transplantation | 16 (2.96) |
- Citation: Rasheed MA, Ballotin VR, Bigarella LG, Soldera J. Post-COVID-19 cholangiopathy: Systematic review. World J Methodol 2023; 13(4): 296-322
- URL: https://www.wjgnet.com/2222-0682/full/v13/i4/296.htm
- DOI: https://dx.doi.org/10.5662/wjm.v13.i4.296